• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声增强化疗药物抑制肿瘤生长的体内实验。

Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experiment.

机构信息

Pharmacy School, Wenzhou Medical College, Zhejiang Province 325035, China.

出版信息

J Drug Target. 2011 Feb;19(2):154-60. doi: 10.3109/10611861003801834. Epub 2010 Apr 30.

DOI:10.3109/10611861003801834
PMID:20429773
Abstract

An in vivo study on enhancing epirubicin hydrochloride (EPI) inhibition on tumor growth by ultrasound (US) was reported. Five-week-old male nude mice were used and HL-60 cells were s.c. (subcutaneous injection) inoculated in axilla of these mice. Six groups were designed and five consecutive treatments were applied to investigate the inhibition on tumor growth and body weight growth. US applied locally to the tumor resulted in a substantially increased drug uptake in tumor cells. The inhibition on tumor growth depended on the position of drug injection and phospholipid-based microbubble (PMB) application. Tumor growth rate under group 1 (PMB+US) was similar to that of blank control. The order of the inhibition on tumor volume growth was: group 4 (s.c. EPI+PMB+US) > group 5 intraperitoneal (i.p. EPI+PMB+US) > group 2 (i.p. EPI) > group 3 (s.c. EPI+US) > group 1 (PMB+US). Similar conclusion was obtained from experimental measurements of tumor weight change. The order of animal survival status for EPI administration groups was: group 4 > group 5 > group 2 > group 3. Chemotherapeutic drug inhibition on tumor growth could be enhanced by local US combined with PMB, which might provide a potential application for US-mediated chemotherapy.

摘要

一项关于超声(US)增强盐酸表柔比星(EPI)抑制肿瘤生长的体内研究报告如下。使用 5 周龄雄性裸鼠,将 HL-60 细胞皮下(SC)接种于这些小鼠的腋窝。设计了 6 组,进行了 5 次连续治疗,以研究对肿瘤生长和体重增长的抑制作用。局部应用 US 可使肿瘤细胞内药物摄取显著增加。肿瘤生长的抑制作用取决于药物注射部位和磷脂基微泡(PMB)的应用。组 1(PMB+US)的肿瘤生长率与空白对照组相似。肿瘤体积生长抑制率的顺序为:组 4(SC EPI+PMB+US)>组 5(腹腔内(IP)EPI+PMB+US)>组 2(IP EPI)>组 3(SC EPI+US)>组 1(PMB+US)。从肿瘤重量变化的实验测量中也得出了类似的结论。EPI 给药组动物的存活状态顺序为:组 4>组 5>组 2>组 3。局部 US 联合 PMB 可增强化疗药物对肿瘤生长的抑制作用,为 US 介导的化疗提供了一种潜在的应用。

相似文献

1
Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experiment.超声增强化疗药物抑制肿瘤生长的体内实验。
J Drug Target. 2011 Feb;19(2):154-60. doi: 10.3109/10611861003801834. Epub 2010 Apr 30.
2
Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles.在体声空化联合磷脂基微泡增强盐酸表柔比星静脉注射的抗肿瘤效应的实验研究。
Cancer Chemother Pharmacol. 2011 Aug;68(2):343-8. doi: 10.1007/s00280-010-1489-4. Epub 2010 Oct 27.
3
Experiment on the factors for enhancing the susceptibility of cancer cells to chemotherapeutic drug by ultrasound microbubbles.超声微泡增强癌细胞对化疗药物敏感性的因素实验。
J Drug Target. 2010 Jul;18(6):430-7. doi: 10.3109/10611860903434043.
4
Synergistic gastric cancer inhibition by chemogenetherapy with recombinant human adenovirus p53 and epirubicin: an in vitro and in vivo study.重组人腺病毒 p53 与表柔比星联合化疗协同抑制胃癌:体外与体内研究。
Oncol Rep. 2010 Dec;24(6):1613-20.
5
Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.体外和体内使用脂质体表阿霉素和针对泵和非泵耐药性的反义寡核苷酸克服多药耐药性。
Biomed Pharmacother. 2013 May;67(4):261-7. doi: 10.1016/j.biopha.2012.12.002. Epub 2012 Dec 21.
6
Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer.表阿霉素聚乙二醇脂质体显著克服乳腺癌多药耐药。
Cancer Lett. 2013 Mar 1;330(1):74-83. doi: 10.1016/j.canlet.2012.11.031. Epub 2012 Nov 24.
7
Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound.胶束包裹药物与超声介导的可控靶向肿瘤化疗
J Control Release. 2005 Jan 20;102(1):203-22. doi: 10.1016/j.jconrel.2004.09.021.
8
New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.新型载多柔比星磷脂微泡用于靶向肿瘤治疗的体内特征研究。
J Control Release. 2010 Dec 20;148(3):368-72. doi: 10.1016/j.jconrel.2010.09.004. Epub 2010 Sep 22.
9
Construction and application of biotin-poloxamer conjugate micelles for chemotherapeutics.构建并应用生物素-聚氧乙烯-聚氧丙烯嵌段共聚物胶束用于化疗药物。
J Microencapsul. 2013;30(6):538-45. doi: 10.3109/02652048.2012.758182. Epub 2013 Mar 14.
10
Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.使用实验设计优化表柔比星纳米颗粒以增强膀胱内给药。
Int J Pharm. 2009 Jul 6;376(1-2):195-203. doi: 10.1016/j.ijpharm.2009.04.045. Epub 2009 May 9.

引用本文的文献

1
Tumor perfusion enhancement by focus ultrasound-induced blood-brain barrier opening to potentiate anti-PD-1 immunotherapy of glioma.聚焦超声诱导血脑屏障开放增强肿瘤灌注以增强胶质瘤的抗PD-1免疫治疗。
Transl Oncol. 2024 Nov;49:102115. doi: 10.1016/j.tranon.2024.102115. Epub 2024 Aug 31.
2
A Novel Platform of MOF for Sonodynamic Therapy Advanced Therapies.用于声动力疗法的新型金属有机框架平台:先进疗法
Pharmaceutics. 2023 Aug 1;15(8):2071. doi: 10.3390/pharmaceutics15082071.
3
Current status and future perspective of sonodynamic therapy for cancer.
癌症声动力治疗的现状与未来展望
J Med Ultrason (2001). 2022 Oct 12. doi: 10.1007/s10396-022-01263-x.
4
Application of Ultrasound Combined with Microbubbles for Cancer Therapy.超声联合微泡在癌症治疗中的应用。
Int J Mol Sci. 2022 Apr 15;23(8):4393. doi: 10.3390/ijms23084393.
5
SonoVue vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?声诺维与声诺素™与欧乃影™:哪种微泡最适合胰腺导管腺癌的低强度超声穿孔?
Pharmaceutics. 2022 Jan 1;14(1):98. doi: 10.3390/pharmaceutics14010098.
6
Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cells.低强度超声穿孔诱导胰腺癌细胞、成纤维细胞和内皮细胞的细胞内信号传导
Pharmaceutics. 2020 Nov 6;12(11):1058. doi: 10.3390/pharmaceutics12111058.
7
Beyond The T/C Ratio: Old And New Anticancer Activity Scores In Vivo.超越T/C比值:体内新旧抗癌活性评分
Cancer Manag Res. 2019 Sep 19;11:8529-8538. doi: 10.2147/CMAR.S215729. eCollection 2019.
8
Ultrasound image-guided therapy enhances antitumor effect of cisplatin.超声图像引导治疗增强顺铂的抗肿瘤效果。
J Med Ultrason (2001). 2014 Jan;41(1):11-21. doi: 10.1007/s10396-013-0475-y. Epub 2013 Jul 17.
9
Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers.利用声动力疗法在临床环境中对抗播散性癌症的前景。
Chemother Res Pract. 2015;2015:316015. doi: 10.1155/2015/316015. Epub 2015 Aug 25.
10
Sonochemotherapy: from bench to bedside.超声化疗:从实验台到临床应用
Front Pharmacol. 2015 Jul 10;6:138. doi: 10.3389/fphar.2015.00138. eCollection 2015.